BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Defeating An inability to embrace success in Scholarly world: Individual Victories - 25 Wellbeing Applications Assist You With remaining Fit
- 3Carnival fever hits Lagos as locals celebrate Afro-Brazilian heritage
- 4The Artemis II launch is tonight. Here's how to watch it live.
- 5'The Drama' plot twist, explained: What did Zendaya's character do, and what happens to her wedding?
- Artemis II updates: NASA's moon mission breaks Apollo record for farthest distance humans have traveled from Earth
- Dozens injured in Russia after train crashes, overturns
- Swap The Amalfi Coast For This Low-Cost Ligurian Seaside Town
- Understanding climate change in America: Skepticism, dogmatism and personal experience
- IDF Home Front Command extends siren warning times for Hezbollah rockets in North
- A Russian fighting for Ukraine conned the Kremlin out of $500,000 by faking his own death
- An Extended time of Self-Reflection: Self-awareness through Journaling
- 'Unreal' solar eclipse: Artemis 2 crew just saw one of the rarest sights in spaceflight history
- NASA's SPHEREx telescope completes its 1st cosmic map of the entire sky and it's stunning!
